Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Ovarian Neoplasms 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Endometrioid 1Carcinoma, Ductal 1Adenocarcinoma 1

Interventions

Carboplatin 49Etoposide 46Cisplatin 42Topotecan 39Irinotecan 21Paclitaxel 20Nivolumab 15pembrolizumab 13Gemcitabine 13atezolizumab 11Ipilimumab 11durvalumab 9Radiotherapy 9Doxorubicin 7Bevacizumab 7rovalpituzumab tesirine 6etoposide phosphate 6amrubicin 6Psychiatric Rehabilitation 6PM 01183 6Docetaxel 6Counseling 6trilaciclib 5Temozolomide 5Sunitinib 5Platinum 5Imatinib Mesylate 5Cyclophosphamide 5Bortezomib 5130-nm albumin-bound paclitaxel 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Small Cell Lung Carcinoma × Radiation, Ionizing × Clear all
NCT00132704 2014-07-24

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Memorial Sloan Kettering Cancer Center

Completed
149 enrolled
DermatologicGastrointestinalGynecologicSarcomaThoracic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid, Carcinoma, Ductal, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡